Back

Real-world outcomes of biweekly and monthly alirocumab regimens: a population-based analysis

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Novel lipid‑lowering therapies for residual risk Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Guang Ming Tan

The Chinese University of Hong Kong, Shatin (Hong Kong)

6 More presentations in this session

Presentation thumbnail
Efficacy of enlicitide, an oral PCSK9 inhibitor, across baseline Lp(a) strata in an analysis of two phase 3 trials
Doctor P. Corral (Mar del Plata, AR)
Abstract Slides Video
Presentation thumbnail
Adherence and legacy effects of high dose eicosapentaenoic acid in hypertriglyceridemia and high CV risk – REDUCE-IT Legacy
Professor C. Packard (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Long term efficacy and adherence of inclisiran in real-world clinical practice: insights from the CHOLINET Registry
Doctor F. Marzano (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Perceived effectiveness of PCSK9i-SiRNA therapy and adherence to background statin therapy: real-world analysis of the DAMAGE registry
Associate Professor F. Guerra (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Determinants of short term Lp(a) variability in phase 3 obicetrapib trials
Doctor J. Kastelein (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Novel lipid‑lowering therapies for residual risk

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment
2 September 2019
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in reducing LDL cholesterol and triglycerides: real-life experience in a third level hospital: a descriptive, bivariate, and multivariate analysis.
4 April 2025
thumbnail
Congress Presentation
Real world outcomes for clopidogrel versus ticagrelor treated patients with acute coronary syndrome: a systematic literature review and meta-analysis
2 September 2019
thumbnail
Congress Presentation
Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk
23 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources